BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 33301008)

  • 1. Dietary protein intake and circulating advanced glycation end product/receptor for advanced glycation end product concentrations in the Health, Aging, and Body Composition Study.
    Brinkley TE; Semba RD; Kritchevsky SB; Houston DK;
    Am J Clin Nutr; 2020 Dec; 112(6):1558-1565. PubMed ID: 33301008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of four differently processed diets with plasma and urine advanced glycation end products and serum soluble receptor for advanced glycation end products concentration in healthy dogs.
    Bridglalsingh S; Archer-Hartmann S; Azadi P; Barbier de La Serre C; Remillard RL; Sunvold GD; Bartges JW
    J Anim Physiol Anim Nutr (Berl); 2024 May; 108(3):735-751. PubMed ID: 38279966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum levels of advanced glycation end-products (AGEs) and the decoy soluble receptor for AGEs (sRAGE) can identify non-alcoholic fatty liver disease in age-, sex- and BMI-matched normo-glycemic adults.
    Palma-Duran SA; Kontogianni MD; Vlassopoulos A; Zhao S; Margariti A; Georgoulis M; Papatheodoridis G; Combet E
    Metabolism; 2018 Jun; 83():120-127. PubMed ID: 29409822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AGE-RAGE Interaction Does Not Explain the Clinical Improvements after Therapeutic Fasting in Osteoarthritis.
    Drinda S; Franke S; Schmidt S; Stoy K; Lehmann T; Wolf G; Neumann T
    Complement Med Res; 2018; 25(3):167-172. PubMed ID: 29433120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Racial differences in circulating levels of the soluble receptor for advanced glycation endproducts in middle-aged and older adults.
    Brinkley TE; Leng X; Nicklas BJ; Kritchevsky SB; Ding J; Kitzman DW; Hundley WG
    Metabolism; 2017 May; 70():98-106. PubMed ID: 28403949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic Fat Content and Liver Enzymes Are Associated with Circulating Free and Protein-Bound Advanced Glycation End Products, Which Are Associated with Low-Grade Inflammation: The CODAM Study.
    Bijnen M; van Greevenbroek MMJ; van der Kallen CJH; Scheijen JL; van de Waarenburg MPH; Stehouwer CDA; Wouters K; Schalkwijk CG
    J Diabetes Res; 2019; 2019():6289831. PubMed ID: 31218233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum levels of advanced glycation end products (AGEs) are increased and their soluble receptor (sRAGE) reduced in Hashimoto's thyroiditis.
    Ruggeri RM; Barbalace MC; Cristani MT; Alibrandi A; Giovinazzo S; Giuffrida G; Trimarchi F; Cannavò S; Campennì A
    J Endocrinol Invest; 2020 Sep; 43(9):1337-1342. PubMed ID: 32232775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in circulating levels of carboxymethyllysine, soluble receptor for advanced glycation end products (sRAGE), and inflammation markers in women during normal pregnancy.
    Quintanilla-García CV; Uribarri J; Fajardo-Araujo ME; Barrientos-Romero JJ; Romero-Gutiérrez G; Reynaga-Ornelas MG; Garay-Sevilla ME
    J Matern Fetal Neonatal Med; 2019 Dec; 32(24):4102-4107. PubMed ID: 29804482
    [No Abstract]   [Full Text] [Related]  

  • 9. Advanced Glycation End-Products (AGEs) and Their Soluble Receptor (sRAGE) in Women Suffering from Systemic Lupus Erythematosus (SLE).
    Nowak A; Przywara-Chowaniec B; Damasiewicz-Bodzek A; Blachut D; Nowalany-Kozielska E; Tyrpień-Golder K
    Cells; 2021 Dec; 10(12):. PubMed ID: 34944030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating soluble receptor for advanced glycation end products is inversely associated with glycemic control and S100A12 protein.
    Basta G; Sironi AM; Lazzerini G; Del Turco S; Buzzigoli E; Casolaro A; Natali A; Ferrannini E; Gastaldelli A
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4628-34. PubMed ID: 16926247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dietary intake of advanced glycation end products did not affect endothelial function and inflammation in healthy adults in a randomized controlled trial.
    Semba RD; Gebauer SK; Baer DJ; Sun K; Turner R; Silber HA; Talegawkar S; Ferrucci L; Novotny JA
    J Nutr; 2014 Jul; 144(7):1037-42. PubMed ID: 24744309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advanced glycation end products and their circulating receptors and level of kidney function in older community-dwelling women.
    Semba RD; Ferrucci L; Fink JC; Sun K; Beck J; Dalal M; Guralnik JM; Fried LP
    Am J Kidney Dis; 2009 Jan; 53(1):51-8. PubMed ID: 18789567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advanced glycation end products, soluble receptor for advanced glycation end products, and risk of colorectal cancer.
    Jiao L; Taylor PR; Weinstein SJ; Graubard BI; Virtamo J; Albanes D; Stolzenberg-Solomon RZ
    Cancer Epidemiol Biomarkers Prev; 2011 Jul; 20(7):1430-8. PubMed ID: 21527578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concentrations of N
    Damasiewicz-Bodzek A; Nowak A
    Biomolecules; 2022 Dec; 12(12):. PubMed ID: 36551298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between serum levels of soluble receptor for advanced glycation end products and circulating advanced glycation end products in type 2 diabetes.
    Tan KC; Shiu SW; Chow WS; Leng L; Bucala R; Betteridge DJ
    Diabetologia; 2006 Nov; 49(11):2756-62. PubMed ID: 16969649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated serum advanced glycation end products and their circulating receptors are associated with anaemia in older community-dwelling women.
    Semba RD; Ferrucci L; Sun K; Patel KV; Guralnik JM; Fried LP
    Age Ageing; 2009 May; 38(3):283-9. PubMed ID: 19252206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma Levels of Free
    Helou C; Nogueira Silva Lima MT; Niquet-Leridon C; Jacolot P; Boulanger E; Delguste F; Guilbaud A; Genin M; Anton PM; Delayre-Orthez C; Papazian T; Howsam M; Tessier FJ
    Nutrients; 2022 Apr; 14(9):. PubMed ID: 35565855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced soluble receptor for advanced glycation end-products (sRAGE) scavenger capacity precedes pre-eclampsia in Type 1 diabetes.
    Yu Y; Hanssen KF; Kalyanaraman V; Chirindel A; Jenkins AJ; Nankervis AJ; Torjesen PA; Scholz H; Henriksen T; Lorentzen B; Garg SK; Menard MK; Hammad SM; Scardo JA; Stanley JR; Wu M; Basu A; Aston CE; Lyons TJ
    BJOG; 2012 Nov; 119(12):1512-20. PubMed ID: 22900949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective study of soluble receptor for advanced glycation end-products and colorectal cancer risk in postmenopausal women.
    Chen L; Duan Z; Tinker L; Sangi-Haghpeykar H; Strickler H; Ho GY; Gunter MJ; Rohan T; Logsdon C; White DL; Royse K; El-Serag HB; Jiao L
    Cancer Epidemiol; 2016 Jun; 42():115-23. PubMed ID: 27100837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decrease in circulating concentrations of soluble receptors for advanced glycation end products at the time of seroconversion to autoantibody positivity in children with prediabetes.
    Salonen KM; Ryhänen SJ; Forbes JM; Borg DJ; Härkönen T; Ilonen J; Simell O; Veijola R; Groop PH; Knip M
    Diabetes Care; 2015 Apr; 38(4):665-70. PubMed ID: 25573878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.